Geoffrey Owen Littlejohn (Geoffrey Littlejohn, Geoffrey O Littlejohn)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 23

Top Topics

Rheumatoid Arthritis

Systematic Review

Radical Prostatectomy

Top Venues

Clinical rheumatology

European journal of rheumatology

International journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Geoffrey Owen Littlejohn, Nithila Anbumurali, Catherine O'Sullivan, Tegan Smith, Kathleen Tymms, Paul Bird, David Nicholls, Hedley Griffiths
Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022. Clinical rheumatology 43 (6) (2024)
Geoffrey Owen Littlejohn, Joanna Leadbetter, Belinda E Butcher, Marie Feletar, Catherine O'Sullivan, Tegan Smith, David Witcombe, Ho Yin Ng, Peter Youssef
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia. Clinical rheumatology 43 (5) (2024)
Geoffrey Owen Littlejohn, Joanna Leadbetter, Belinda E Butcher, Marie Feletar, Catherine O'Sullivan, Tegan Smith, David Witcombe, Ho Yin Ng, Peter Youssef
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia. Clinical rheumatology (2024)
Geoffrey Owen Littlejohn, Nithila Anbumurali, Catherine O'Sullivan, Tegan Smith, Kathleen Tymms, Paul Bird, David Nicholls, Hedley Griffiths
Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022. Clinical rheumatology (2024)
Geoffrey Owen Littlejohn, Joanna Leadbetter, Belinda E Butcher, Marie Feletar, Catherine O'Sullivan, Tegan Smith, David Witcombe, Ho Yin Ng, Peter Youssef
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia. Clinical rheumatology 43 (5) (2024)
Geoffrey Owen Littlejohn, Nithila Anbumurali, Catherine O'Sullivan, Tegan Smith, Kathleen Tymms, Paul Bird, David Nicholls, Hedley Griffiths
Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022. Clinical rheumatology 43 (6) (2024)
Geoffrey Owen Littlejohn, Joanna Leadbetter, Belinda E Butcher, Marie Feletar, Catherine O'Sullivan, Tegan Smith, David Witcombe, Ho Yin Ng, Peter Youssef
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia. Clinical rheumatology 43 (5) (2024)
Geoffrey Owen Littlejohn, Joanna Leadbetter, Belinda E Butcher, Marie Feletar, Catherine O'Sullivan, Tegan Smith, David Witcombe, Ho Yin Ng, Peter Youssef
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia. Clinical rheumatology 43 (5) (2024)
Geoffrey Owen Littlejohn, Joanna Leadbetter, Belinda E Butcher, Marie Feletar, Catherine O'Sullivan, Tegan Smith, David Witcombe, Ho Yin Ng, Peter Youssef
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia. Clinical rheumatology 43 (5) (2024)
Geoffrey Owen Littlejohn, Joanna Leadbetter, Belinda E Butcher, Marie Feletar, Catherine O'Sullivan, Tegan Smith, David Witcombe, Ho Yin Ng, Peter Youssef
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia. Clinical rheumatology 43 (5) (2024)
Geoffrey Owen Littlejohn, Nithila Anbumurali, Catherine O'Sullivan, Tegan Smith, Kathleen Tymms, Paul Bird, David Nicholls, Hedley Griffiths
Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022. Clinical rheumatology 43 (6) (2024)
Geoffrey Owen Littlejohn, Nithila Anbumurali, Catherine O'Sullivan, Tegan Smith, Kathleen Tymms, Paul Bird, David Nicholls, Hedley Griffiths
Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022. Clinical rheumatology 43 (6) (2024)
Sabina Ciciriello, Geoffrey Owen Littlejohn, Tamas Treuer, Kathryn A Gibson, Ewa Haladyj, Peter Youssef, Paul Bird, Catherine O'Sullivan, Tegan Smith, Claire T Deakin, null null
Comparative Effectiveness of First-Line Baricitinib in Patients With Rheumatoid Arthritis in the Australian OPAL Data Set. ACR open rheumatology (2023)
Sabina Ciciriello, Geoffrey Owen Littlejohn, Catherine O'Sullivan, Tegan Smith, Claire T Deakin
Burden of disease and real-world treatment patterns of patients with systemic lupus erythematosus in the Australian OPAL dataset. Clinical rheumatology (2023)
Claire T Deakin, Geoffrey Owen Littlejohn, Hedley Griffiths, Sabina Ciciriello, Catherine O'Sullivan, Tegan Smith, Peter Youssef, Paul Bird, null null
Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost-savings. Internal medicine journal (2023)
Paul Bird, Geoffrey Owen Littlejohn, Belinda E Butcher, Tegan Smith, Catherine O'Sullivan, David Witcombe, Hedley Griffiths
Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia. Clinical rheumatology (2021)
Geoffrey Owen Littlejohn
Fibromyalgia and psoriatic arthritis: Partners together. International journal of rheumatic diseases 24 (2) (2021)
Kathleen Tymms, Belinda E Butcher, Tracey L Sletten, Tegan Smith, Catherine O'Sullivan, Geoffrey Owen Littlejohn, Ricky Sadler, Rebecca Tronnberg, Hedley Griffiths, null null
Prevalence of sleep disturbance and the association between poor disease control in people with ankylosing spondylitis within the Australian clinical setting (ASLEEP study): a real-world observational study using the OPAL dataset. Clinical rheumatology (2021)
Paul Bird, Geoffrey Owen Littlejohn, Belinda E Butcher, Tegan Smith, Candida da Fonseca Pereira, David Witcombe, Hedley Griffiths
Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia. Clinical rheumatology 39 (9) (2020)
Kathleen Tymms, Belinda E Butcher, Tegan Smith, Geoffrey Owen Littlejohn, null null
Impact of anti-citrullinated protein antibody on tumor necrosis factor inhibitor or abatacept response in patients with rheumatoid arthritis. European journal of rheumatology (2020)
Geoffrey Owen Littlejohn, Emma K Guymer
Key Milestones Contributing to the Understanding of the Mechanisms Underlying Fibromyalgia. Biomedicines 8 (7) (2020)
Geoffrey Owen Littlejohn, Emma K Guymer
Chronic pain syndromes: overlapping phenotypes with common mechanisms. F1000Research 8 (2019)
Lynden Roberts, Kathleen Tymms, Julien de Jager, Geoffrey Owen Littlejohn, Hedley Griffiths, Dave Nicholls, Paul Bird, Jennifer Young, Julie Hill, Jane Zochling
The CEDAR Study: A Longitudinal Study of the Clinical Effects of Conventional DMARDs and Biologic DMARDs in Australian Rheumatology Practice. International journal of rheumatology 2017 (2017)